Literature DB >> 26883432

Long-term follow-up of renal arteries after radio-frequency catheter-based denervation using optical coherence tomography and angiography.

Tomasz Roleder1, Mariusz Skowerski2, Andrzej Wiecek3, Marcin Adamczak3, Beata Czerwienska3, Wojciech Wanha4, Tomasz Jadczyk4, Lukasz Partyka5, Grzegorz Smolka4, Wacław Kuczmik6, Andrzej Ochała4, Dariusz Dudek7, Michał Tendera4, Zbigniew Gasior2, Wojciech Wojakowski4.   

Abstract

Optical coherence tomography (OCT) imaging at the time of renal denervation (RDN) showed that procedure might cause spasm, intimal injury or thrombus formation. In the present study, we assessed the healing of renal arteries after RDN using OCT and renal angiography in long-term follow-up. OCT and renal angiography were performed in 12 patients (22 arteries) 18.41 ± 5.83 months after RNS. There were no adverse events or complications during the long-term follow-up. In ten patients (83 %), significant reductions of blood pressure was achieved without a change of the antihypertensive medications. We demonstrated the presence of 26 areas of focal intimal thickening identified by OCT in 10 (83 %) patients and in 14 (63 %) arteries. The mean area of focal intimal thickening was 0.054 ± 0.033 mm(2). No vessel dissection, thrombus, intimal tear or acute vasospasm were observed during the OCT analysis. Also, the quantitative angiography analysis revealed a significant reduction of the minimal and proximal lumen diameters at follow-up as compared to measurements obtained before RDN. Renal arteries have a favorable "long-term" vessel healing response after RDN. Focal intimal thickening and a modest reduction of the minimal lumen diameter may be observed after RF denervation. Further studies are needed to determine whether intravascular imaging may be helpful in evaluating the vessel healing of RF RDN.

Entities:  

Keywords:  Intimal thickening; Optical coherence tomography; Renal denervation; Vessel healing

Mesh:

Substances:

Year:  2016        PMID: 26883432     DOI: 10.1007/s10554-016-0853-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  15 in total

1.  Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Authors:  Michel Azizi; Marc Sapoval; Philippe Gosse; Matthieu Monge; Guillaume Bobrie; Pascal Delsart; Marco Midulla; Claire Mounier-Véhier; Pierre-Yves Courand; Pierre Lantelme; Thierry Denolle; Caroline Dourmap-Collas; Hervé Trillaud; Helena Pereira; Pierre-François Plouin; Gilles Chatellier
Journal:  Lancet       Date:  2015-01-26       Impact factor: 79.321

2.  Renal artery stenosis after renal sympathetic denervation.

Authors:  Benjamin Kaltenbach; Dani Id; Jennifer C Franke; Horst Sievert; Marcus Hennersdorf; Jens Maier; Stefan C Bertog
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

3.  Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.

Authors:  Murray D Esler; Henry Krum; Markus Schlaich; Roland E Schmieder; Michael Böhm; Paul A Sobotka
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

4.  Bilateral renal artery stenosis after renal denervation.

Authors:  Fernando Jaén Águila; Juan Diego Mediavilla García; Eduardo Molina Navarro; Jose Antonio Vargas Hitos; Celia Fernández-Torres
Journal:  Hypertension       Date:  2014-03-24       Impact factor: 10.190

5.  Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Authors: 
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

6.  Influence of renal denervation on vascular responsiveness of isolated rat intrarenal arteries.

Authors:  E D Högestätt; O Johansson; K E Andersson; C M Kullendorff
Journal:  Acta Physiol Scand       Date:  1988-01

7.  De novo renal artery stenosis after renal sympathetic denervation.

Authors:  Ibrahim E Celik; Burak Acar; Alparslan Kurtul; Sani N Murat
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-27       Impact factor: 3.738

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter.

Authors:  Christian Templin; Milosz Jaguszewski; Jelena R Ghadri; Isabella Sudano; Roman Gaehwiler; Jens P Hellermann; Renate Schoenenberger-Berzins; Ulf Landmesser; Paul Erne; Georg Noll; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2013-04-25       Impact factor: 29.983

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  3 in total

1.  Laparoscopic-based perivascular renal sympathetic nerve denervation: a feasibility study in a porcine model.

Authors:  Linwei Zhao; Enyong Su; Xiaohang Yang; Binbin Zhu; Zhiqiang Fan; Xianpei Wang; Datun Qi; Lijie Zhu; Mingfu Bai; You Zhang; Qiuping Zhao; Muwei Li; Chuanyu Gao
Journal:  Eur J Med Res       Date:  2020-06-18       Impact factor: 2.175

2.  Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Degang Ding; Zhonghua Liu; Zhiqiang Fan; Qiuping Zhao; You Zhang; Jiguang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

3.  Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV-Risk Study.

Authors:  Marit D Solbu; Atena Miroslawska; Jon V Norvik; Bjørn O Eriksen; Terje K Steigen
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.